Micro-X Ltd. (AU:MX1)
ASX:MX1
Want to see AU:MX1 full AI Analyst Report?
MX1 Stock Chart & Stats
AU$0.10
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.10
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.04 - AU$0.12
Previous CloseN/A
Volume191.73K
Average Volume (3M)189.28K
Market Cap
AU$28.44M
Enterprise ValueAU$30.13M
Total Cash (Recent Filing)AU$4.90M
Total Debt (Recent Filing)AU$5.13M
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding729,233,000
10 Day Avg. Volume131,613
30 Day Avg. Volume189,275
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)3.96
Price to Sales (P/S)2.29
P/FCF Ratio-3.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.15Price Target Upside50.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)AU$26.90M
Bulls Say, Bears Say
Bulls Say
Proprietary Cold-cathode CNT X-ray TechnologyMicro-X's carbon-nanotube cold-cathode X-ray tube is a durable technological moat. Its compact, lightweight form factor uniquely suits field-deployable medical and security uses, creating product differentiation, specialized channels and higher switching costs that support long-term market positions.
Strong Gross Margins (79.05%)A reported 79.05% gross margin indicates attractive unit economics for Micro-X hardware. High gross margins provide structural capacity to fund R&D and SG&A, enable pricing power, and if volume increases, support operating leverage and a durable pathway toward profitability.
Diversified Product And Service Revenue StreamsMicro-X sells systems, X-ray tubes/components and after-sales services across medical and security markets. This multi-channel revenue mix reduces reliance on a single product sale, creates recurring service opportunities, and supports steadier long-term cash conversion as installed base grows.
Bears Say
Declining Revenue TrendReported revenue decline of -9.52% signals challenged demand or execution. Sustained top-line contraction undermines fixed-cost absorption, limits the ability to scale R&D and commercialization, and makes it harder to convert high gross margins into durable operating profits.
Persistent UnprofitabilityOngoing negative net profit and EBIT/EBITDA margins mean the business cannot self-fund growth or absorb shocks. Persistent losses increase reliance on external capital, risk dilution, and constrain long-term investments needed to penetrate medical and defence channels at scale.
Negative Cash Flow And Rising LeverageNegative operating and free cash flows, alongside rising leverage noted elsewhere, reduce financial flexibility. Weak cash generation elevates refinancing risk, limits ability to invest in commercialization or regulatory work, and heightens vulnerability during prolonged adoption cycles.
Micro-X Ltd. News
MX1 FAQ
What was Micro-X Ltd.’s price range in the past 12 months?
Micro-X Ltd. lowest share price was AU$0.04 and its highest was AU$0.12 in the past 12 months.
What is Micro-X Ltd.’s market cap?
Micro-X Ltd.’s market cap is AU$28.44M.
When is Micro-X Ltd.’s upcoming earnings report date?
Micro-X Ltd.’s upcoming earnings report date is Aug 27, 2026 which is in 84 days.
How were Micro-X Ltd.’s earnings last quarter?
Micro-X Ltd. released its earnings results on Feb 26, 2026. The company reported -AU$0.01 earnings per share for the quarter, missing the consensus estimate of -AU$0.006 by -AU$0.004.
Is Micro-X Ltd. overvalued?
According to Wall Street analysts Micro-X Ltd.’s price is currently Undervalued.
Does Micro-X Ltd. pay dividends?
Micro-X Ltd. does not currently pay dividends.
What is Micro-X Ltd.’s EPS estimate?
Micro-X Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Micro-X Ltd. have?
Micro-X Ltd. has 729,233,000 shares outstanding.
What happened to Micro-X Ltd.’s price movement after its last earnings report?
Micro-X Ltd. reported an EPS of -AU$0.01 in its last earnings report, missing expectations of -AU$0.006. Following the earnings report the stock price went up 15.385%.
Which hedge fund is a major shareholder of Micro-X Ltd.?
Currently, no hedge funds are holding shares in AU:MX1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Micro-X Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.15 (50.00% Upside)
AU$0.15 (50.00% Upside)
Blogger Sentiment
Bullish
AU:MX1 Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$200.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.40%
12-Months-Change
Fundamentals
Return on Equity
-180.06%
Trailing 12-Months
Asset Growth
-12.76%
Trailing 12-Months
Company Description
Micro-X Ltd.
Micro-X Limited designs, develops, and manufactures lightweight carbon nano tube-based X-ray products for the healthcare and security imaging markets in Australia. The company offers rover veterinary, a mobile X-ray machine to diagnose and treat animals for general veterinarian practices; Carestream DRX Revolution Nano, a mobile X-ray imaging machine used for high intensity workflow diagnostic medical imaging in hospitals; and IED X-ray cameras. It also provides miniature baggage scanners to detect hidden threats concealed within passenger carry-on luggage; airport screening reimagined, a passenger self-screening airport checkpoint; and brain CT scanners for use in road and air ambulances. The company was incorporated in 2011 and is based in Tonsley, Australia.
MX1 Stock 12 Month Forecast
Average Price Target
AU$0.15
▲(50.00% Upside)
Technical Analysis
Cyclopharm Limited
―
CleanSpace Holdings Ltd.
―
EMvision Medical Devices Ltd.
―
Control Bionics Ltd.
―
4DMedical Ltd
―
Options Prices
Currently, No data available
---